Alternatives to Adaptam Therapeutics
Adaptam Therapeutics is a Biotech tool: developing novel therapeutics for rare genetic diseases with a focus on protein degradation. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to Adaptam Therapeutics
- Website
TippingPoint Biosciences59BiotechCambridge, USA$14.5MDeveloping novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.
- Website
Hexagon Bio57BiotechMenlo Park, United States$100.0MDeveloping novel therapeutics by understanding the complex interplay of biological systems.
- Website
Avidity Biosciences53BiotechSan Diego, United States$495.0MClinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.
- Website
Orchard Therapeutics51BiotechBoston, United States$125.0MGene therapy company developing treatments for rare inherited diseases.
- Website CSCSF Biosciences48BiotechCambridge, United States$15.0M
Develops novel protein engineering and directed evolution technologies for therapeutic discovery.
- Website
Editas Medicine42BiotechCambridge, United States$210.0MA clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Intellia Therapeutics40BiotechCambridge, United States$310.0MA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
- Website OMOmega Therapeutics61BiotechCambridge, United States
Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.
- Website
Eleven Therapeutics56HealthcareLondon, United Kingdom$22.0MIsraeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.
- Website
Gene Bio Medical36BiotechTel Aviv, Israel$10.0MDevelops advanced gene editing and cell therapy solutions for rare genetic diseases.
- Website
Goldenrod Therapeutics, .34BiotechSan Diego, United States$1.0MDeveloping novel therapeutics for rare and underserved diseases.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Adaptive Biotechnologies69BiotechSeattle, United States$300.0MLeveraging the adaptive immune system to diagnose and treat disease.
- Website
Beam Therapeutics47WorkflowsCambridge, United States$235.0MA biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases.
- Website
BeiGene64BiotechCambridge, United States$358.0MA global oncology company developing and commercializing innovative cancer treatments.
- Website
BioSymetrics63BiotechBoston, United States$6.6MPhenomics-driven AI company translating disease biology into precision medicine discoveries.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website LELexeo Therapeutics61BiotechNew York City, United States$495.0M
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Showing the 20 closest matches. See the rest on the Adaptam Therapeutics profile.
Compare Adaptam Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.